2021 Q2 Form 10-Q Financial Statement
#000156459021032072 Filed on June 08, 2021
Income Statement
| Concept | 2021 Q2 | 2020 Q2 |
|---|---|---|
| Revenue | $70.13M | $54.65M |
| YoY Change | 28.34% | 15.8% |
| Cost Of Revenue | $26.37M | $22.63M |
| YoY Change | 16.54% | 17.02% |
| Gross Profit | $43.77M | $32.02M |
| YoY Change | 36.68% | 14.96% |
| Gross Profit Margin | 62.4% | 58.6% |
| Selling, General & Admin | $16.03M | $13.44M |
| YoY Change | 19.29% | 2.74% |
| % of Gross Profit | 36.62% | 41.96% |
| Research & Development | $37.87M | $34.20M |
| YoY Change | 10.74% | 3.58% |
| % of Gross Profit | 86.54% | 106.81% |
| Depreciation & Amortization | $600.0K | $700.0K |
| YoY Change | -14.29% | 0.0% |
| % of Gross Profit | 1.37% | 2.19% |
| Operating Expenses | $53.90M | $47.64M |
| YoY Change | 13.15% | 3.34% |
| Operating Profit | -$10.14M | -$15.62M |
| YoY Change | -35.09% | -14.4% |
| Interest Expense | ||
| YoY Change | ||
| % of Operating Profit | ||
| Other Income/Expense, Net | $593.0K | $1.278M |
| YoY Change | -53.6% | -41.8% |
| Pretax Income | -$9.543M | -$14.34M |
| YoY Change | -33.44% | -10.65% |
| Income Tax | $1.300M | $1.100M |
| % Of Pretax Income | ||
| Net Earnings | -$10.82M | -$15.46M |
| YoY Change | -30.04% | -10.68% |
| Net Earnings / Revenue | -15.42% | -28.3% |
| Basic Earnings Per Share | -$0.30 | -$0.45 |
| Diluted Earnings Per Share | -$0.30 | -$0.45 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 35.94M | 34.08M |
| Diluted Shares Outstanding | 35.94M | 34.08M |
Balance Sheet
| Concept | 2021 Q2 | 2020 Q2 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $435.5M | $411.3M |
| YoY Change | 5.89% | 12.32% |
| Cash & Equivalents | $227.5M | $236.6M |
| Short-Term Investments | $208.0M | $174.7M |
| Other Short-Term Assets | $5.371M | $4.800M |
| YoY Change | 11.9% | -4.0% |
| Inventory | $33.12M | $21.96M |
| Prepaid Expenses | ||
| Receivables | $34.53M | $20.70M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $508.5M | $458.8M |
| YoY Change | 10.84% | 10.47% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $6.308M | $5.401M |
| YoY Change | 16.79% | -62.23% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $15.12M | $15.30M |
| YoY Change | -1.21% | 18.6% |
| Total Long-Term Assets | $76.09M | $72.90M |
| YoY Change | 4.38% | 13.91% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $508.5M | $458.8M |
| Total Long-Term Assets | $76.09M | $72.90M |
| Total Assets | $584.6M | $531.7M |
| YoY Change | 9.96% | 10.93% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $20.64M | $20.60M |
| YoY Change | 0.21% | 27.95% |
| Accrued Expenses | $47.89M | $29.40M |
| YoY Change | 62.89% | 18.07% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $70.00M | $51.50M |
| YoY Change | 35.93% | 21.99% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $14.87M | $17.26M |
| YoY Change | -13.88% | 29.78% |
| Total Long-Term Liabilities | $14.87M | $17.26M |
| YoY Change | -13.88% | 29.78% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $70.00M | $51.50M |
| Total Long-Term Liabilities | $14.87M | $17.26M |
| Total Liabilities | $93.34M | $76.20M |
| YoY Change | 22.5% | 34.15% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $491.3M | $455.6M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $584.6M | $531.7M |
| YoY Change | 9.96% | 10.93% |
Cashflow Statement
| Concept | 2021 Q2 | 2020 Q2 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$10.82M | -$15.46M |
| YoY Change | -30.04% | -10.68% |
| Depreciation, Depletion And Amortization | $600.0K | $700.0K |
| YoY Change | -14.29% | 0.0% |
| Cash From Operating Activities | -$4.547M | $7.639M |
| YoY Change | -159.52% | 43.27% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$1.954M | $428.0K |
| YoY Change | -556.54% | -16.57% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$9.276M | -$1.700M |
| YoY Change | 445.65% | -147.22% |
| Cash From Investing Activities | -$11.23M | -$2.164M |
| YoY Change | 418.95% | -169.31% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $0.00 | $1.000M |
| YoY Change | -100.0% | |
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 2.012M | -293.0K |
| YoY Change | -786.69% | -115.08% |
| NET CHANGE | ||
| Cash From Operating Activities | -4.547M | 7.639M |
| Cash From Investing Activities | -11.23M | -2.164M |
| Cash From Financing Activities | 2.012M | -293.0K |
| Net Change In Cash | -13.77M | 5.182M |
| YoY Change | -365.63% | -50.16% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$4.547M | $7.639M |
| Capital Expenditures | -$1.954M | $428.0K |
| Free Cash Flow | -$2.593M | $7.211M |
| YoY Change | -135.96% | 49.64% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y5M15D | |
| CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y6M21D | |
| CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
17128000 | |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10818000 | |
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
491294000 | |
| CY2020Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
6463000 | |
| CY2020Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
2660000 | |
| CY2020Q2 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
1000000 | |
| CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
15214000 | |
| CY2020Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-363000 | |
| CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15463000 | |
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
455583000 | |
| CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-10818000 | |
| CY2020Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-15463000 | |
| CY2021Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2883000 | |
| CY2020Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2872000 | |
| CY2021Q2 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-417000 | |
| CY2020Q2 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-10000 | |
| CY2021Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
18842000 | |
| CY2020Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
16036000 | |
| CY2021Q2 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
433000 | |
| CY2020Q2 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
457000 | |
| CY2021Q2 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
190000 | |
| CY2020Q2 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
38000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9554000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2197000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
7039000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1014000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-161000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-193000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
65000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-351000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-480000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
5679000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
1969000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-1343000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-262000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
58000 | |
| CY2021Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-74000 | |
| CY2020Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
101000 | |
| CY2021Q2 | amba |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-856000 | |
| CY2020Q2 | amba |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-689000 | |
| CY2021Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4547000 | |
| CY2020Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
7639000 | |
| CY2021Q2 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
57117000 | |
| CY2020Q2 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
49077000 | |
| CY2021Q2 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
18609000 | |
| CY2020Q2 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
13601000 | |
| CY2021Q2 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
29232000 | |
| CY2020Q2 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
33740000 | |
| CY2021Q2 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
1954000 | |
| CY2020Q2 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
428000 | |
| CY2021Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-11230000 | |
| CY2020Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2164000 | |
| CY2021Q2 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | |
| CY2020Q2 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
1000000 | |
| CY2021Q2 | amba |
Proceeds From Issuance Of Shares Under Incentive Equity Plan And Employee Stock Purchase Plan
ProceedsFromIssuanceOfSharesUnderIncentiveEquityPlanAndEmployeeStockPurchasePlan
|
3893000 | |
| CY2020Q2 | amba |
Proceeds From Issuance Of Shares Under Incentive Equity Plan And Employee Stock Purchase Plan
ProceedsFromIssuanceOfSharesUnderIncentiveEquityPlanAndEmployeeStockPurchasePlan
|
1912000 | |
| CY2021Q2 | amba |
Payment For Intangible Asset
PaymentForIntangibleAsset
|
1881000 | |
| CY2020Q2 | amba |
Payment For Intangible Asset
PaymentForIntangibleAsset
|
1205000 | |
| CY2021Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2012000 | |
| CY2020Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-293000 | |
| CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-13765000 | |
| CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5182000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
231412000 | |
| CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
227519000 | |
| CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
236594000 | |
| CY2021Q2 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1013000 | |
| CY2020Q2 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
370000 | |
| CY2021Q2 | amba |
Capital Expenditures Incurred But Not Yet Paid And Financing Incurred For Tangible And Intangible Asset Purchased
CapitalExpendituresIncurredButNotYetPaidAndFinancingIncurredForTangibleAndIntangibleAssetPurchased
|
304000 | |
| CY2020Q2 | amba |
Capital Expenditures Incurred But Not Yet Paid And Financing Incurred For Tangible And Intangible Asset Purchased
CapitalExpendituresIncurredButNotYetPaidAndFinancingIncurredForTangibleAndIntangibleAssetPurchased
|
67000 | |
| CY2021Q2 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:18pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, management evaluates its estimates and assumptions, including those related to (i) write down of excess and obsolete inventories; (ii) the estimated useful lives of long-lived assets; (iii) the valuation of stock-based compensation awards and financial instruments; (iv) the probability of performance objectives achievement; and (v) the realization of tax assets and estimates of tax liabilities, including reserves for uncertain tax positions. These estimates and assumptions are based on historical experience and on various other factors which the Company believes to be reasonable under the circumstances. The Company may engage third-party valuation specialists to assist with estimates related to the valuation of financial instruments, assets and stock awards associated with various contractual arrangements. Such estimates often require the selection of appropriate valuation methodologies and significant judgment. Actual results could differ from these estimates under different assumptions or circumstances and such differences could be material. </p> <p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> also assessed the </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">impacts </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">COVID-19 </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">on the above accounting matters as of April 30, 2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and through the date of this report. While </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it is difficult to quantify the impact of COVID-19</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the future </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">magnitude and duration of COVID-19, as well as other </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">associated </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">factors, could r</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">esult in material negative impacts to the Company’s </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">condensed consolidated financial statements</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> in future reporting periods</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> | |
| CY2021Q1 | amba |
Available For Sale Securities Debt Maturities Within One To Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneToThreeYearsFairValue
|
78903000 | |
| CY2021Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
214861000 | |
| CY2021Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
214802000 | |
| CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
241274000 | |
| CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
236585000 | |
| CY2020Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
231403000 | |
| CY2021Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
10000 | |
| CY2020Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
9000 | |
| CY2020Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
9000 | |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
241284000 | |
| CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
236594000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
231412000 | |
| CY2021Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | |
| CY2020Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
1226000 | |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
7000 | |
| CY2021Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
214069000 | |
| CY2021Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
832000 | |
| CY2021Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
213583000 | |
| CY2021Q2 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
|
0 | |
| CY2021Q2 | amba |
Available For Sale Securities Debt Maturities Within One Year
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYear
|
134814000 | |
| CY2021Q1 | amba |
Available For Sale Securities Debt Maturities Within One Year
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYear
|
135899000 | |
| CY2021Q2 | amba |
Available For Sale Securities Debt Maturities Within One To Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneToThreeYearsFairValue
|
80047000 | |
| CY2021Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
24497000 | |
| CY2021Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
18219000 | |
| CY2021Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
8623000 | |
| CY2021Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
7862000 | |
| CY2021Q2 | us-gaap |
Inventory Net
InventoryNet
|
33120000 | |
| CY2021Q1 | us-gaap |
Inventory Net
InventoryNet
|
26081000 | |
| CY2021Q2 | us-gaap |
Depreciation
Depreciation
|
600000 | |
| CY2020Q2 | us-gaap |
Depreciation
Depreciation
|
700000 | |
| CY2021Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
23362000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
22008000 | |
| CY2021Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
17054000 | |
| CY2021Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
16478000 | |
| CY2021Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
6308000 | |
| CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
5530000 | |
| CY2021Q2 | amba |
Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Current
LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueCurrent
|
5600000 | |
| CY2021Q2 | amba |
Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Noncurrent
LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueNoncurrent
|
4200000 | |
| CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
25225000 | |
| CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
7934000 | |
| CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
17291000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
6440000 | |
| CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
18703000 | |
| CY2021Q2 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
0 | |
| CY2020Q2 | us-gaap |
Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
|
0 | |
| CY2021Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
13049000 | |
| CY2021Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
18105000 | |
| CY2021Q2 | amba |
Accrued Rebates
AccruedRebates
|
621000 | |
| CY2021Q1 | amba |
Accrued Rebates
AccruedRebates
|
391000 | |
| CY2021Q2 | amba |
Accrued Development Cost Liabilities
AccruedDevelopmentCostLiabilities
|
22354000 | |
| CY2021Q1 | amba |
Accrued Development Cost Liabilities
AccruedDevelopmentCostLiabilities
|
21157000 | |
| CY2021Q2 | amba |
Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Current
LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueCurrent
|
5596000 | |
| CY2021Q1 | amba |
Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Current
LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueCurrent
|
5582000 | |
| CY2021Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
3277000 | |
| CY2021Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
2891000 | |
| CY2021Q2 | amba |
Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
|
44897000 | |
| CY2021Q1 | amba |
Accrued And Other Liabilities Current
AccruedAndOtherLiabilitiesCurrent
|
48126000 | |
| CY2021Q1 | amba |
Payments For Bonus
PaymentsForBonus
|
6700000 | |
| CY2021Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
800000 | |
| CY2020Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
700000 | |
| CY2021Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
856000 | |
| CY2021Q2 | amba |
Lease Liabilities Arising From Obtaining Right Of Use Assets For Operating Lease
LeaseLiabilitiesArisingFromObtainingRightOfUseAssetsForOperatingLease
|
89000 | |
| CY2021Q2 | amba |
Leased Assets Obtained In Exchange For Operating Lease Liabilities Arising From Lease Modifications
LeasedAssetsObtainedInExchangeForOperatingLeaseLiabilitiesArisingFromLeaseModifications
|
1687000 | |
| CY2021Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y2M12D | |
| CY2021Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0382 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
2559000 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
2918000 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
2698000 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
2625000 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
1180000 | |
| CY2021Q2 | amba |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
278000 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
12258000 | |
| CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
791000 | |
| CY2021Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
11467000 | |
| CY2021Q2 | amba |
Closing Market Price Of Ordinary Shares On Nasdaq On Last Day Of Reporting Period
ClosingMarketPriceOfOrdinarySharesOnNASDAQOnLastDayOfReportingPeriod
|
97.49 | |
| CY2021Q2 | amba |
Unrecognized Tax Benefits Including Interest
UnrecognizedTaxBenefitsIncludingInterest
|
9052000 | |
| CY2021Q1 | amba |
Unrecognized Tax Benefits Including Interest
UnrecognizedTaxBenefitsIncludingInterest
|
8966000 | |
| CY2021Q2 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
1287000 | |
| CY2021Q1 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
1288000 | |
| CY2021Q2 | amba |
Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Noncurrent
LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueNoncurrent
|
4226000 | |
| CY2021Q1 | amba |
Liabilities Associated With Noncancelable Internal Use Software License At Net Present Value Noncurrent
LiabilitiesAssociatedWithNoncancelableInternalUseSoftwareLicenseAtNetPresentValueNoncurrent
|
6259000 | |
| CY2021Q2 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
301000 | |
| CY2021Q1 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
299000 | |
| CY2021Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
14866000 | |
| CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
16812000 | |
| CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | |
| CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
20000000 | |
| CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00045 | |
| CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00045 | |
| CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2021Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | |
| CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | |
| CY2021Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
18842000 | |
| CY2020Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
16036000 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
651709 | |
| CY2021Q2 | amba |
Accrued Share Based Compensation Expense
AccruedShareBasedCompensationExpense
|
1700000 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
719143 | |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
38.33 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
13100 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
111.51 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
40.98 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
37040000 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
51.10 | |
| CY2021Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
77403 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
27.77 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
6363000 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
3131 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
55.43 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
531761 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
36.80 | |
| CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
32298000 | |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10818000 | |
| CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15463000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
35940304 | |
| CY2020Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
34080330 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
35940304 | |
| CY2020Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
34080330 | |
| CY2021Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.30 | |
| CY2020Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.45 | |
| CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.30 | |
| CY2020Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.45 | |
| CY2021Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2236983 | |
| CY2020Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2244323 | |
| CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-9543000 | |
| CY2020Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-14337000 | |
| CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1275000 | |
| CY2020Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1126000 | |
| CY2021Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.134 | |
| CY2020Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.079 | |
| CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1300000 | |
| CY2020Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1100000 | |
| CY2021Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
27800000 | |
| CY2021Q2 | us-gaap |
Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
|
67600000 | |
| CY2021Q1 | us-gaap |
Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
|
48200000 | |
| CY2021Q2 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | |
| CY2021Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
70133000 | |
| CY2020Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
54645000 |
